AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.

OSI Pharmaceuticals Announces Conference Call On Earlier Announced FDA Approval Of Tarceva -TM- For Patients With Advanced Non-Small Cell Lung Cancer - Abstract.

Europe Intelligence Wire

| November 19, 2004 | COPYRIGHT 2003 Financial Times Ltd. (Hide copyright information)Copyright

(From Corporate Conference Call Abstracts)

CORPORATE CONFERENCE CALL ABSTRACTS-19 November 2004-OSI Pharmaceuticals Announces Conference Call On Earlier Announced FDA Approval Of Tarceva -TM- For Patients With Advanced Non-Small Cell Lung Cancer - Abstract (C)2004 Research and Markets (http://www.researchandmarkets.com/).

The OSI Pharmaceuticals, Inc. (OSIP) Corporate Conference Call took place on 19-Nov-04 …

Related articles from newspapers, magazines, journals, and more
OSI Pharmaceuticals Conference Call To Discuss (OSI) Eyetech Integration...
News wire article from: Europe Intelligence Wire November 21, 2005 700+ words
OSI Pharmaceuticals, Inc. Conference Call - Abstract.
News wire article from: Europe Intelligence Wire August 22, 2005 700+ words
Q4 2004 OSI Pharmaceuticals, Inc. Earnings Conference Call - Final.
News wire article from: Fair Disclosure Wire November 29, 2004 700+ words
Q4 2005 OSI Pharmaceuticals, Inc. Earnings Conference Call - Research and...
News wire article from: Europe Intelligence Wire March 8, 2006 700+ words
Q3 2007 OSI Pharmaceuticals, Inc. Earnings Conference Call - Final.
News wire article from: Fair Disclosure Wire October 25, 2007 700+ words
©2013 Gale, a part of Cengage Learning. All rights reserved. Contact us | Privacy policy | Terms and conditions

The AccessMyLibrary advertising network includes: womensforum.com GlamFamily